OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders
Yu‐Hua Lin, Bing‐Juin Chiang, Chun‐Hou Liao
Toxins (2020) Vol. 12, Iss. 2, pp. 129-129
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
Siro Luvisetto
Toxins (2021) Vol. 13, Iss. 11, pp. 751-751
Open Access | Times Cited: 42

Endoscopic injection of botulinum toxin to prevent pouch contractions in a patient with Indiana pouch diversion
Emre Albayrak, Naşide Mangır, Hasan Doğan, et al.
Therapeutic Advances in Urology (2025) Vol. 17
Open Access

Chronic pelvic pain and botulinum toxin
Barbara I. Karp, Pamela Stratton
Toxicon (2025), pp. 108336-108336
Closed Access

Neurogenic Bladder in Children with Myelomeningocele
Aleksandar Sič, Borko Stojanović, Miroslav Đorđević
Diseases (2025) Vol. 13, Iss. 4, pp. 117-117
Open Access

Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Toxins (2024) Vol. 16, Iss. 7, pp. 309-309
Open Access | Times Cited: 3

Update on Overactive Bladder Therapeutic Options
Caroline P. Babin, Nicole T. Catalano, David M. Yancey, et al.
American Journal of Therapeutics (2023) Vol. 31, Iss. 4, pp. e410-e419
Closed Access | Times Cited: 8

Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis
Xingpeng Di, Deyi Luo, Xi Jin, et al.
International Urogynecology Journal (2021) Vol. 32, Iss. 5, pp. 1129-1141
Closed Access | Times Cited: 16

Correction of overactive bladder with botulinum toxin type A (BTX-A)
Andrey Grishin, Anastasiya Spaska, Lyailya N. Kayumova
Toxicon (2021) Vol. 200, pp. 96-101
Closed Access | Times Cited: 13

The Response of the Urinary Microbiome to Botox
Kasey M. Palm, Megan K. Abrams, Sarah Sears, et al.
International Urogynecology Journal (2024) Vol. 35, Iss. 1, pp. 237-251
Closed Access | Times Cited: 1

Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review
Ellen Kelsey, Jessica Wynn, Angela Holmes, et al.
Neurourology and Urodynamics (2024) Vol. 43, Iss. 3, pp. 553-564
Open Access | Times Cited: 1

Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review
Saereh Hosseindoost, Seyed Hassan Inanloo, Seyed Khalil Pestehei, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 1

The use of Botulinum toxin in various urological conditions
Vitalii Kondratskyi, Piotr Nawrot, Ada Szepelska, et al.
Wiadomości Lekarskie (2024) Vol. 77, Iss. 2, pp. 348-352
Closed Access | Times Cited: 1

An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders
Yunfeng Gao, Lai Fei, Junbo Liu, et al.
International Urology and Nephrology (2022) Vol. 54, Iss. 3, pp. 479-491
Closed Access | Times Cited: 7

Bladder Dysfunction in Older Adults: The Botulinum Toxin Option
Yao‐Lin Kao, Yin‐Chien Ou, Hann‐Chorng Kuo
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 401-416
Closed Access | Times Cited: 7

The clinical pharmacology of the medical treatment for overactive bladder in adults
Hadi Mostafaei, Shahrokh F. Shariat, Hanieh Salehi‐Pourmehr, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 7, pp. 707-720
Closed Access | Times Cited: 10

An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity
Leslie Peard, John C. Pope, Roger R. Dmochowski
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 9, pp. 763-774
Closed Access | Times Cited: 3

Voiding and storage symptoms in depression/anxiety
Ryuji Sakakibara, Shuichi Katsuragawa
Autonomic Neuroscience (2021) Vol. 237, pp. 102927-102927
Closed Access | Times Cited: 7

Changes in brain response to urgency before and after treatment of urgency urinary incontinence with onabotulinumtoxin A
Becky Clarkson, Helmet T. Karim, Christopher Chermansky, et al.
Neurourology and Urodynamics (2022) Vol. 41, Iss. 8, pp. 1703-1710
Closed Access | Times Cited: 5

Perioperative Techniques for the Use of Botulinum Toxin in Overactive Bladder: Results of a Multinational Online Survey of Urogynecologists in Germany, Austria, and Switzerland
Sören Lange, Marianne Koch, Rainer Lange, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1462-1462
Open Access | Times Cited: 2

Clinical Guidelines of Patient-Centered Bladder Management of Neurogenic Lower Urinary Tract Dysfunction due to Chronic Spinal Cord Injury - Part 2
Yao‐Lin Kao, Jianting Chen, Sung-Lang Chen, et al.
Urological Science (2023) Vol. 34, Iss. 1, pp. 10-17
Open Access | Times Cited: 2

Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence
Margarida Manso, João Diogo Soares, Margarida Henriques, et al.
Toxins (2024) Vol. 16, Iss. 8, pp. 332-332
Open Access

Page 1 - Next Page

Scroll to top